3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
9
Venous Thromboembolism
4
Prostatic Neoplasms
3
Polycythemia Vera
3
Neoplasms
3
Breast Neoplasms
3
Myeloproliferative Disorders
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Ovarian Neoplasms
1
Ovarian Cancer Prevention
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms, Germ Cell and Embryonal
1
Multiple Myeloma
1
Motor Activity
1
Lung Neoplasms
1
Liver Cirrhosis
1
Leukemia, Hairy Cell
1
Inflammation
1
Hemorrhage
1
Hematoma
1
Fibrosis
1
Endometrial Neoplasms
1
Interventions
tremelimumab
1
epigallocatechin gallate
1
durvalumab
1
babao dan
1
Urination
1
Standard of Care
1
Rosuvastatin Calcium
1
Preoperative Exercise
1
Furosemide
1
Erlotinib Hydrochloride
1
Digoxin
1
Diagnostic Imaging
1
Control Groups
1
Cannabidiol
1
Breathing Exercises
1
Breath Tests
1
Blood Specimen Collection
1
Aspirin
1
Anti-HIV Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Cirrhosis
×
Aspirin
×
1 year
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled